RESEND: TruScreen begins selling TruScreen2 devices to China

RESEND: TruScreen begins selling TruScreen2 devices to China
Rebecca Howard
(Fixes typo in headline) By Rebecca Howard Dec. 21 (BusinessDesk) - NZAX-listed TruScreen has received payment for an initial order from its Chinese distributor following China Food and Drug Administration approval for its TruScreen2 device. The Auckland-based cervical cancer test developer said it has received $188,000 as an initial payment for the new device. "The company is now producing consoles at its maximum capacity to meet current and anticipated orders from China which is our largest target market," said TruScreen chair Robert...